Clinical Trial Update: Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer [Phase 3]

View source ↗

Summary

This update describes a Phase 3 trial evaluating zoledronic acid as adjuvant therapy for triple-negative breast cancer. The study is sponsored by the Chinese Ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Triple Negative Breast Cancer | Phase 3 | Status: UNKNOWN